Key Takeaways

The 'black box' warning about breast cancer, stroke and heart attack risk is coming off many menopause hormone therapy meds

Officials say the warnings were based on outdated 2002 study data involving older patients and old drug formulas

Doctors can now recommend that women start HRT early — before age 60

WEDNESDAY, Nov. 12, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

The decision affects products containing estrogen or progestogen, alone or combined, that are prescribed to treat troublesome menopause symptoms like hot flashes, mood swings and sleep difficulty, and to r

See Full Page